2018-2023 Global Pneumonia Vaccine Consumption Market Report

Publisher Name :
Date: 11-Oct-2018
No. of pages: 136

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Pneumonia Vaccine market for 2018-2023.

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.

Over the next five years, LPI(LP Information) projects that Pneumonia Vaccine will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumonia Vaccine market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Pneumococcal Conjugate Vaccine (PCV13)

- Pneumococcal Polysaccharide Vaccine (PPSV23)

Segmentation by application:

- Pneumonia

- Meningitis

- Sepsis

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Pfizer Inc.

- Glaxosmithkline Plc.

- Merck & Co., Inc.

- Sanofi Pasteur

- Serum Institute of India Pvt. Ltd.

- Johnson & Johnson

- Astellas Pharma Inc.

- Astrazeneca Plc.

- CSL Limited

- Emergent Biosolutions

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Pneumonia Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Pneumonia Vaccine market by identifying its various subsegments.

- Focuses on the key global Pneumonia Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Pneumonia Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Pneumonia Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Pneumonia Vaccine Consumption Market Report

Table of Contents

2018-2023 Global Pneumonia Vaccine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumonia Vaccine Consumption 2013-2023
2.1.2 Pneumonia Vaccine Consumption CAGR by Region
2.2 Pneumonia Vaccine Segment by Type
2.2.1 Pneumococcal Conjugate Vaccine (PCV13)
2.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
2.3 Pneumonia Vaccine Consumption by Type
2.3.1 Global Pneumonia Vaccine Consumption Market Share by Type (2013-2018)
2.3.2 Global Pneumonia Vaccine Revenue and Market Share by Type (2013-2018)
2.3.3 Global Pneumonia Vaccine Sale Price by Type (2013-2018)
2.4 Pneumonia Vaccine Segment by Application
2.4.1 Pneumonia
2.4.2 Meningitis
2.4.3 Sepsis
2.5 Pneumonia Vaccine Consumption by Application
2.5.1 Global Pneumonia Vaccine Consumption Market Share by Application (2013-2018)
2.5.2 Global Pneumonia Vaccine Value and Market Share by Application (2013-2018)
2.5.3 Global Pneumonia Vaccine Sale Price by Application (2013-2018)

3 Global Pneumonia Vaccine by Players
3.1 Global Pneumonia Vaccine Sales Market Share by Players
3.1.1 Global Pneumonia Vaccine Sales by Players (2016-2018)
3.1.2 Global Pneumonia Vaccine Sales Market Share by Players (2016-2018)
3.2 Global Pneumonia Vaccine Revenue Market Share by Players
3.2.1 Global Pneumonia Vaccine Revenue by Players (2016-2018)
3.2.2 Global Pneumonia Vaccine Revenue Market Share by Players (2016-2018)
3.3 Global Pneumonia Vaccine Sale Price by Players
3.4 Global Pneumonia Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Pneumonia Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Pneumonia Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pneumonia Vaccine by Regions
4.1 Pneumonia Vaccine by Regions
4.1.1 Global Pneumonia Vaccine Consumption by Regions
4.1.2 Global Pneumonia Vaccine Value by Regions
4.2 Americas Pneumonia Vaccine Consumption Growth
4.3 APAC Pneumonia Vaccine Consumption Growth
4.4 Europe Pneumonia Vaccine Consumption Growth
4.5 Middle East & Africa Pneumonia Vaccine Consumption Growth

5 Americas
5.1 Americas Pneumonia Vaccine Consumption by Countries
5.1.1 Americas Pneumonia Vaccine Consumption by Countries (2013-2018)
5.1.2 Americas Pneumonia Vaccine Value by Countries (2013-2018)
5.2 Americas Pneumonia Vaccine Consumption by Type
5.3 Americas Pneumonia Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Pneumonia Vaccine Consumption by Countries
6.1.1 APAC Pneumonia Vaccine Consumption by Countries (2013-2018)
6.1.2 APAC Pneumonia Vaccine Value by Countries (2013-2018)
6.2 APAC Pneumonia Vaccine Consumption by Type
6.3 APAC Pneumonia Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Pneumonia Vaccine by Countries
7.1.1 Europe Pneumonia Vaccine Consumption by Countries (2013-2018)
7.1.2 Europe Pneumonia Vaccine Value by Countries (2013-2018)
7.2 Europe Pneumonia Vaccine Consumption by Type
7.3 Europe Pneumonia Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Pneumonia Vaccine by Countries
8.1.1 Middle East & Africa Pneumonia Vaccine Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Pneumonia Vaccine Value by Countries (2013-2018)
8.2 Middle East & Africa Pneumonia Vaccine Consumption by Type
8.3 Middle East & Africa Pneumonia Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Pneumonia Vaccine Distributors
10.3 Pneumonia Vaccine Customer

11 Global Pneumonia Vaccine Market Forecast
11.1 Global Pneumonia Vaccine Consumption Forecast (2018-2023)
11.2 Global Pneumonia Vaccine Forecast by Regions
11.2.1 Global Pneumonia Vaccine Forecast by Regions (2018-2023)
11.2.2 Global Pneumonia Vaccine Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pneumonia Vaccine Forecast by Type
11.8 Global Pneumonia Vaccine Forecast by Application

12 Key Players Analysis
12.1 Pfizer Inc.
12.1.1 Company Details
12.1.2 Pneumonia Vaccine Product Offered
12.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Pfizer Inc. News
12.2 Glaxosmithkline Plc.
12.2.1 Company Details
12.2.2 Pneumonia Vaccine Product Offered
12.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Glaxosmithkline Plc. News
12.3 Merck & Co., Inc.
12.3.1 Company Details
12.3.2 Pneumonia Vaccine Product Offered
12.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Merck & Co., Inc. News
12.4 Sanofi Pasteur
12.4.1 Company Details
12.4.2 Pneumonia Vaccine Product Offered
12.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sanofi Pasteur News
12.5 Serum Institute of India Pvt. Ltd.
12.5.1 Company Details
12.5.2 Pneumonia Vaccine Product Offered
12.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Serum Institute of India Pvt. Ltd. News
12.6 Johnson & Johnson
12.6.1 Company Details
12.6.2 Pneumonia Vaccine Product Offered
12.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Johnson & Johnson News
12.7 Astellas Pharma Inc.
12.7.1 Company Details
12.7.2 Pneumonia Vaccine Product Offered
12.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Astellas Pharma Inc. News
12.8 Astrazeneca Plc.
12.8.1 Company Details
12.8.2 Pneumonia Vaccine Product Offered
12.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Astrazeneca Plc. News
12.9 CSL Limited
12.9.1 Company Details
12.9.2 Pneumonia Vaccine Product Offered
12.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 CSL Limited News
12.10 Emergent Biosolutions
12.10.1 Company Details
12.10.2 Pneumonia Vaccine Product Offered
12.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Emergent Biosolutions News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Pneumonia Vaccine
Table Product Specifications of Pneumonia Vaccine
Figure Pneumonia Vaccine Report Years Considered
Figure Market Research Methodology
Figure Global Pneumonia Vaccine Consumption Growth Rate 2013-2023 (K Doses)
Figure Global Pneumonia Vaccine Value Growth Rate 2013-2023 ($ Millions)
Table Pneumonia Vaccine Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Pneumococcal Conjugate Vaccine (PCV13)
Table Major Players of Pneumococcal Conjugate Vaccine (PCV13)
Figure Product Picture of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table Major Players of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table Global Consumption Sales by Type (2013-2018)
Table Global Pneumonia Vaccine Consumption Market Share by Type (2013-2018)
Figure Global Pneumonia Vaccine Consumption Market Share by Type (2013-2018)
Table Global Pneumonia Vaccine Revenue by Type (2013-2018) ($ million)
Table Global Pneumonia Vaccine Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Pneumonia Vaccine Value Market Share by Type (2013-2018)
Table Global Pneumonia Vaccine Sale Price by Type (2013-2018)
Figure Pneumonia Vaccine Consumed in Pneumonia
Figure Global Pneumonia Vaccine Market: Pneumonia (2013-2018) (K Doses)
Figure Global Pneumonia Vaccine Market: Pneumonia (2013-2018) ($ Millions)
Figure Global Pneumonia YoY Growth ($ Millions)
Figure Pneumonia Vaccine Consumed in Meningitis
Figure Global Pneumonia Vaccine Market: Meningitis (2013-2018) (K Doses)
Figure Global Pneumonia Vaccine Market: Meningitis (2013-2018) ($ Millions)
Figure Global Meningitis YoY Growth ($ Millions)
Figure Pneumonia Vaccine Consumed in Sepsis
Figure Global Pneumonia Vaccine Market: Sepsis (2013-2018) (K Doses)
Figure Global Pneumonia Vaccine Market: Sepsis (2013-2018) ($ Millions)
Figure Global Sepsis YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Pneumonia Vaccine Consumption Market Share by Application (2013-2018)
Figure Global Pneumonia Vaccine Consumption Market Share by Application (2013-2018)
Table Global Pneumonia Vaccine Value by Application (2013-2018)
Table Global Pneumonia Vaccine Value Market Share by Application (2013-2018)
Figure Global Pneumonia Vaccine Value Market Share by Application (2013-2018)
Table Global Pneumonia Vaccine Sale Price by Application (2013-2018)
Table Global Pneumonia Vaccine Sales by Players (2016-2018) (K Doses)
Table Global Pneumonia Vaccine Sales Market Share by Players (2016-2018)
Figure Global Pneumonia Vaccine Sales Market Share by Players in 2016
Figure Global Pneumonia Vaccine Sales Market Share by Players in 2017
Table Global Pneumonia Vaccine Revenue by Players (2016-2018) ($ Millions)
Table Global Pneumonia Vaccine Revenue Market Share by Players (2016-2018)
Figure Global Pneumonia Vaccine Revenue Market Share by Players in 2016
Figure Global Pneumonia Vaccine Revenue Market Share by Players in 2017
Table Global Pneumonia Vaccine Sale Price by Players (2016-2018)
Figure Global Pneumonia Vaccine Sale Price by Players in 2017
Table Global Pneumonia Vaccine Manufacturing Base Distribution and Sales Area by Players
Table Players Pneumonia Vaccine Products Offered
Table Pneumonia Vaccine Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Pneumonia Vaccine Consumption by Regions 2013-2018 (K Doses)
Table Global Pneumonia Vaccine Consumption Market Share by Regions 2013-2018
Figure Global Pneumonia Vaccine Consumption Market Share by Regions 2013-2018
Table Global Pneumonia Vaccine Value by Regions 2013-2018 ($ Millions)
Table Global Pneumonia Vaccine Value Market Share by Regions 2013-2018
Figure Global Pneumonia Vaccine Value Market Share by Regions 2013-2018
Figure Americas Pneumonia Vaccine Consumption 2013-2018 (K Doses)
Figure Americas Pneumonia Vaccine Value 2013-2018 ($ Millions)
Figure APAC Pneumonia Vaccine Consumption 2013-2018 (K Doses)
Figure APAC Pneumonia Vaccine Value 2013-2018 ($ Millions)
Figure Europe Pneumonia Vaccine Consumption 2013-2018 (K Doses)
Figure Europe Pneumonia Vaccine Value 2013-2018 ($ Millions)
Figure Middle East & Africa Pneumonia Vaccine Consumption 2013-2018 (K Doses)
Figure Middle East & Africa Pneumonia Vaccine Value 2013-2018 ($ Millions)
Table Americas Pneumonia Vaccine Consumption by Countries (2013-2018) (K Doses)
Table Americas Pneumonia Vaccine Consumption Market Share by Countries (2013-2018)
Figure Americas Pneumonia Vaccine Consumption Market Share by Countries in 2017
Table Americas Pneumonia Vaccine Value by Countries (2013-2018) ($ Millions)
Table Americas Pneumonia Vaccine Value Market Share by Countries (2013-2018)
Figure Americas Pneumonia Vaccine Value Market Share by Countries in 2017
Table Americas Pneumonia Vaccine Consumption by Type (2013-2018) (K Doses)
Table Americas Pneumonia Vaccine Consumption Market Share by Type (2013-2018)
Figure Americas Pneumonia Vaccine Consumption Market Share by Type in 2017
Table Americas Pneumonia Vaccine Consumption by Application (2013-2018) (K Doses)
Table Americas Pneumonia Vaccine Consumption Market Share by Application (2013-2018)
Figure Americas Pneumonia Vaccine Consumption Market Share by Application in 2017
Figure United States Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure United States Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Canada Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Canada Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Mexico Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Mexico Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Table APAC Pneumonia Vaccine Consumption by Countries (2013-2018) (K Doses)
Table APAC Pneumonia Vaccine Consumption Market Share by Countries (2013-2018)
Figure APAC Pneumonia Vaccine Consumption Market Share by Countries in 2017
Table APAC Pneumonia Vaccine Value by Countries (2013-2018) ($ Millions)
Table APAC Pneumonia Vaccine Value Market Share by Countries (2013-2018)
Figure APAC Pneumonia Vaccine Value Market Share by Countries in 2017
Table APAC Pneumonia Vaccine Consumption by Type (2013-2018) (K Doses)
Table APAC Pneumonia Vaccine Consumption Market Share by Type (2013-2018)
Figure APAC Pneumonia Vaccine Consumption Market Share by Type in 2017
Table APAC Pneumonia Vaccine Consumption by Application (2013-2018) (K Doses)
Table APAC Pneumonia Vaccine Consumption Market Share by Application (2013-2018)
Figure APAC Pneumonia Vaccine Consumption Market Share by Application in 2017
Figure China Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure China Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Japan Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Japan Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Korea Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Korea Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Southeast Asia Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure India Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure India Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Australia Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Australia Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Table Europe Pneumonia Vaccine Consumption by Countries (2013-2018) (K Doses)
Table Europe Pneumonia Vaccine Consumption Market Share by Countries (2013-2018)
Figure Europe Pneumonia Vaccine Consumption Market Share by Countries in 2017
Table Europe Pneumonia Vaccine Value by Countries (2013-2018) ($ Millions)
Table Europe Pneumonia Vaccine Value Market Share by Countries (2013-2018)
Figure Europe Pneumonia Vaccine Value Market Share by Countries in 2017
Table Europe Pneumonia Vaccine Consumption by Type (2013-2018) (K Doses)
Table Europe Pneumonia Vaccine Consumption Market Share by Type (2013-2018)
Figure Europe Pneumonia Vaccine Consumption Market Share by Type in 2017
Table Europe Pneumonia Vaccine Consumption by Application (2013-2018) (K Doses)
Table Europe Pneumonia Vaccine Consumption Market Share by Application (2013-2018)
Figure Europe Pneumonia Vaccine Consumption Market Share by Application in 2017
Figure Germany Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Germany Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure France Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure France Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure UK Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure UK Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Italy Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Italy Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Russia Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Russia Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Spain Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Spain Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Pneumonia Vaccine Consumption by Countries (2013-2018) (K Doses)
Table Middle East & Africa Pneumonia Vaccine Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Pneumonia Vaccine Consumption Market Share by Countries in 2017
Table Middle East & Africa Pneumonia Vaccine Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Pneumonia Vaccine Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Pneumonia Vaccine Value Market Share by Countries in 2017
Table Middle East & Africa Pneumonia Vaccine Consumption by Type (2013-2018) (K Doses)
Table Middle East & Africa Pneumonia Vaccine Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Pneumonia Vaccine Consumption Market Share by Type in 2017
Table Middle East & Africa Pneumonia Vaccine Consumption by Application (2013-2018) (K Doses)
Table Middle East & Africa Pneumonia Vaccine Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Pneumonia Vaccine Consumption Market Share by Application in 2017
Figure Egypt Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Egypt Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure South Africa Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure South Africa Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Israel Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Israel Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure Turkey Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure Turkey Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Pneumonia Vaccine Consumption Growth 2013-2018 (K Doses)
Figure GCC Countries Pneumonia Vaccine Value Growth 2013-2018 ($ Millions)
Table Pneumonia Vaccine Distributors List
Table Pneumonia Vaccine Customer List
Figure Global Pneumonia Vaccine Consumption Growth Rate Forecast (2018-2023) (K Doses)
Figure Global Pneumonia Vaccine Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Pneumonia Vaccine Consumption Forecast by Countries (2018-2023) (K Doses)
Table Global Pneumonia Vaccine Consumption Market Forecast by Regions
Table Global Pneumonia Vaccine Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Pneumonia Vaccine Value Market Share Forecast by Regions
Figure Americas Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Americas Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure APAC Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure APAC Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Europe Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Europe Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Middle East & Africa Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Middle East & Africa Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure United States Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure United States Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Canada Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Canada Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Mexico Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Mexico Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Brazil Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Brazil Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure China Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure China Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Japan Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Japan Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Korea Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Korea Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Southeast Asia Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Southeast Asia Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure India Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure India Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Australia Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Australia Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Germany Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Germany Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure France Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure France Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure UK Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure UK Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Italy Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Italy Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Russia Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Russia Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Spain Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Spain Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Egypt Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Egypt Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure South Africa Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure South Africa Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Israel Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Israel Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure Turkey Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure Turkey Pneumonia Vaccine Value 2018-2023 ($ Millions)
Figure GCC Countries Pneumonia Vaccine Consumption 2018-2023 (K Doses)
Figure GCC Countries Pneumonia Vaccine Value 2018-2023 ($ Millions)
Table Global Pneumonia Vaccine Consumption Forecast by Type (2018-2023) (K Doses)
Table Global Pneumonia Vaccine Consumption Market Share Forecast by Type (2018-2023)
Table Global Pneumonia Vaccine Value Forecast by Type (2018-2023) ($ Millions)
Table Global Pneumonia Vaccine Value Market Share Forecast by Type (2018-2023)
Table Global Pneumonia Vaccine Consumption Forecast by Application (2018-2023) (K Doses)
Table Global Pneumonia Vaccine Consumption Market Share Forecast by Application (2018-2023)
Table Global Pneumonia Vaccine Value Forecast by Application (2018-2023) ($ Millions)
Table Global Pneumonia Vaccine Value Market Share Forecast by Application (2018-2023)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Inc. Pneumonia Vaccine Market Share (2016-2018)
Table Glaxosmithkline Plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Glaxosmithkline Plc. Pneumonia Vaccine Market Share (2016-2018)
Table Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck & Co., Inc. Pneumonia Vaccine Market Share (2016-2018)
Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Pasteur Pneumonia Vaccine Market Share (2016-2018)
Table Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Pneumonia Vaccine Market Share (2016-2018)
Table Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharma Inc. Pneumonia Vaccine Market Share (2016-2018)
Table Astrazeneca Plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astrazeneca Plc. Pneumonia Vaccine Market Share (2016-2018)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Limited Pneumonia Vaccine Market Share (2016-2018)
Table Emergent Biosolutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent Biosolutions Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Emergent Biosolutions Pneumonia Vaccine Market Share (2016-2018)
  • Global Polypeptide Drug Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 111
    The global Polypeptide Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Polypeptide Drug market based on company, product type, end user and key regions. This report studies the global market size of Polypeptide Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa......
  • Global Lactulose Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Mar-2019        Price: US 3480 Onwards        Pages: 121
    Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. Scope of the Report: Lactulose industry is concentrated relatively and is technology int......
  • Global Urokinase Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 117
    Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin. T......
  • Global Thin Film Drugs Market Size, Status and Forecast 2019-2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 101
    Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. The classification of Thin Film Drugs includes transdermal film, oral thin film and other types, and the proportion of transdermal film is about 72......
  • Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 114
    Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump). The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion ......
  • Global Paracetamol Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 125
    Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness. In the world the production of paracetamol is highly concentrated in China and India, the two countries occupy about 83.86% of the global production (China 59.02% and India 24.84%) in 2016, and their market sha......
  • Global Mycophenolate Mofetil Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 115
    The global Mycophenolate Mofetil market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mycophenolate Mofetil market based on company, product type, end user and key regions. This report studies the global market size of Mycophenolate Mofetil in key regions like North America, Europe, Asia Pacific, Central & South America and Middl......
  • Global Hyoscine-N-Butyl Bromide Market Insights, Forecast to 2026
    Published: 18-Mar-2019        Price: US 3900 Onwards        Pages: 117
    This report researches the worldwide Hyoscine-N-Butyl Bromide market size (value, capacity, production and consumption) in key regions like Europe, India and other regions. This study categorizes the global Hyoscine-N-Butyl Bromide breakdown data by manufacturers, region and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Fo......
  • Global All Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Mar-2019        Price: US 3480 Onwards        Pages: 123
    A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorgani......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs